First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: A systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

Rheumatology (United Kingdom)

Volumn 51, Issue 8, 2012, Pages 1388-1396

  Van den berg, Rosaline ^a   Baraliakos, Xenofon ^b   Braun, Jürgen ^b   Van der heijde, Désirée ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RHEUMAZENTRUM RUHRGEBIET   (Germany)

Author keywords

Ankylosing spondylitis; Management; Recommendations; Systematic literature review

Indexed keywords

CELECOXIB; DICLOFENAC; ETANERCEPT; ETORICOXIB; KETOPROFEN; METHOTREXATE; PLACEBO;

ANKYLOSING SPONDYLITIS; ARTICLE; BALNEOTHERAPY; COCHRANE LIBRARY; DATA BASE; DISEASE ACTIVITY; EFFECT SIZE; EMBASE; FUNCTIONAL STATUS; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PAIN; PATIENT MOBILITY; PHYSIOTHERAPY; PRIORITY JOURNAL; SPA TREATMENT; SPINAL ANESTHESIA; SPINE MOBILITY; SPINE SURGERY; SYSTEMATIC REVIEW; TOTAL HIP PROSTHESIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; BALNEOLOGY; EXERCISE THERAPY; HUMANS; SPONDYLITIS, ANKYLOSING;

EID: 84865174836     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes066     Document Type: Article

References (48)

1. Braun J, Pham T, Sieper J et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
2. van der Heijde D, Landewe R, Baraliakos X et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008;58:3063-70.
3. Zochling J, van der Heijde D, Burgos-Vargas R et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006;65:442-52.
4. Zochling J, van der Heijde D, Dougados M, Braun J. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Ann Rheum Dis 2006;65:423-32.
5. Baraliakos X, Listing J, Rudwaleit M et al. Radiographic progression in patients with ankylosing spondylitis after years of treatment with the tumour necrosis factor alpha antibody infliximab. Ann Rheum Dis 2005;64:1462-6.
6. Braun J, Brandt J, Listing J, Zink A et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
7. Davis JC, van der Heijde D, Braun J et al. Recombinant human tumor necrosis factor receptor, (etanercept) for treating ankylosing spondylitis-a randomized, controlled trial. Arthritis Rheum 2003;48:3230-6.
8. van der Heijde D, Kivitz A, Schiff MH et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006;54:2136-46.
9. Braun J, van den Berg R, Baraliakos X et al. update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011;70:896-904.
10. Karapolat H, Akkoc Y, Sari I et al. Comparison of group-based exercise versus home-based exercise in patients with ankylosing spondylitis: effects on Bath Ankylosing Spondylitis Indices, quality of life and depression. Clin Rheumatol 2008;27:695-700.
11. Ortancil O, Sarikaya S, Sapmaz P, Basaran A, Ozdolap S. The effect(s) of a six-week home-based exercise program on the respiratory muscle and functional status in ankylosing spondylitis. J Clin Rheumatol 2009;15:68-70.
12. Widberg K, Hossein K, Hafstrom I. Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis-a randomized study. Clin Rehabil 2009;23: 599-608.
13. Cagliyan A, Kotevoglu N, Onal T, Tekkus B, Kuran B. Does group exercise program add anything more to patients with ankylosing spondylitis? J Back Musculoskelet Rehabil 2007;20:79-85.
14. Durmus D, Alayli G, Cil E, Canturk F. Effects of a home-based exercise program on quality of life, fatigue, and depression in patients with ankylosing spondylitis. Rheumatol Int 2009;29:673-7.
15. Durmus D, Alayli G, Uzun O et al. Effects of two exercise interventions on pulmonary functions in the patients with ankylosing spondylitis. Joint Bone Spine 2009;76:150-5.
16. Gurcay E, Yuzer S, Eksioglu E, Bal A, Cakci A. Stanger bath therapy for ankylosing spondylitis: illusion or reality? Clin Rheumatol 2008;27:913-7.
17. Yurtkuran M, Ay A, Karakoc Y. Improvement of the clinical outcome in ankylosing spondylitis by balneotherapy. Joint Bone Spine 2005;72:303-8.
18. Lubrano E, D'Angelo S, Parsons WJ et al. Effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria. Rheumatology 2007;46: 1672-5.
19. Sieper J, Klopsch T, Richter M et al. Comparison of two different dosages of celecoxib with diclofenac for the treatment of AS treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Ann Rheum Dis 2008;67:323-9.
20. Jarrett SJ, Sivera F, Cawkwell LS et al. MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. Ann Rheum Dis 2009;68:1466-9.
21. Braun J, Zochling J, Baraliakos X et al. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis 2006;65:1147-53.
22. Braun J, van der Horst-Bruinsma I, Huang F et al. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial. Arthritis Rheum 2011;63:1543-51.
23. Genc H, Duyur CB, Nacir B et al. The effects of sulfasalazine treatment on enthesal abnormalities of inflammatory rheumatic diseases. Clin Rheumatol 2007; 26:1104-10.
24. Haibel H, Brandt HC, Song IH et al. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Ann Rheum Dis 2007;66:419-21.
25. Alberding A, Stierle H, Brandt J, Braun J. Effectiveness and safety of radium chloride in the treatment of ankylosing spondylitis. Results of an observational study. Z Rheumatol 2006;65:245-51.
26. Li J, Xu WD, Xu L, Liang ZM. Hip resurfacing arthroplasty for ankylosing spondylitis. J Arthroplasty 2009;24: 1285-91.
27. Chang KW, Tu MY, Huang HH et al. Posterior correction and fixation without anterior fusion for pseudoarthrosis with kyphotic deformity in ankylosing spondylitis. Spine 2006;31:E408-13.
28. Chang KW, Chen YY, Lin CC, Hsu HL, Pai KC. Closing wedge osteotomy versus opening wedge osteotomy in ankylosing spondylitis with thoracolumbar kyphotic deformity. Spine 2005;30:1584-93.
29. Belanger TA, Milam RA IV, Roh JS, Bohlman HH. Cervicothoracic extension osteotomy for chin-on-chest deformity in ankylosing spondylitis. J Bone Joint Surg Am 2005;87:1732-8.
30. Simmons ED, DiStefano RJ, Zheng Y, Simmons EH. Thirty-six years experience of cervical extension osteotomy in ankylosing spondylitis: techniques and outcomes. Spine 2006;31:3006-12.
31. Kim KT, Lee SH, Suk KS, Lee JH, Im YJ. Spinal pseudarthrosis in advanced ankylosing spondylitis with sagittal plane deformity: clinical characteristics and outcome analysis. Spine 2007;32:1641-7.
32. Min K, Hahn F, Leonardi M. Lumbar spinal osteotomy for kyphosis in ankylosing spondylitis: the significance of the whole body kyphosis angle. J Spinal Disord Tech 2007;20: 149-53.
33. Langeloo DD, Journee HL, Pavlov PW, de Kleuver M. Cervical osteotomy in ankylosing spondylitis: evaluation of new developments. Eur Spine J 2006;15:493-500.
34. Tokala DP, Lam KS, Freeman BJ, Webb JK. C7 decancellisation closing wedge osteotomy for the correction of fixed cervico-thoracic kyphosis. Eur Spine J 2007;16:1471-8.
35. Brox JI, Helle A, Sorensen R et al. Functional outcome after lumbar closing wedge osteotomy in ankylosing spondylitis. Int Orthop 2009;33:1049-53.
36. Wu JR, Jiang GY, Wei W. Confidence intervals of effect size in randomized comparative parallel-group studies. Stat Med 2006;25:639-51.
37. Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 2008; CD002822.
38. Fernandez-de-Las-Penas C, Alonso-Blanco C, Morales-Cabezas M, Miangolarra-Page JC. Two exercise interventions for the management of patients with ankylosing spondylitis: a randomized controlled trial. Am J Phys Med Rehabil 2005;84:407-19.
39. Fernandez-de-Las-Penas C, Alonso-Blanco C, Alguacil-Diego IM, Miangolarra-Page JC. One-year follow-up of two exercise interventions for the management of patients with ankylosing spondylitis: a randomized controlled trial. Am J Phys Med Rehabil 2006; 85:559-67.
40. Ince G, Sarpel T, Durgun B, Erdogan S. Effects of a multimodal exercise program for people with ankylosing spondylitis. Phys Ther 2006;86:924-35.
41. Wanders A, van der Heijde D, Landewe R et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005;52: 1756-65.
42. Codish S, Dobrovinsky S, Abu SM, Flusser D, Sukenik S. Spa therapy for ankylosing spondylltis at the Dead Sea. Isr Med Assoc J 2005;7:443-6.
43. Altan L, Bingol U, Aslan M, Yurtkuran M. The effect of balneotherapy on patients with ankylosing spondylitis. Scand J Rheumatol 2006;35:283-9.
44. Dougados M, Behier JM, Jolchine I et al. Efficacy of celecoxib, acyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis-a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum 2001;44:180-5.
45. Chen J, Liu C, Lin J. Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev 2006; CD004524.
46. Chen J, Liu C. Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev 2005;CD004800.
47. Brophy S, Burrows CL, Brooks C et al. Internet-based randomised controlled trials for the evaluation of complementary and alternative medicines: probiotics in spondyloarthropathy. BMC Musculoskelet Disord 2008;9:4.
48. Cohen D. Out of joint: the story of the ASR. BMJ 2011;342: d2905.